Nephron Pharmaceuticals is a women-owned manufacturer of generic respiratory inhalation solutions that proudly offers Racepinephrine 2.25%, Albuterol Sulfate 0.5%, 0.083%, 0.042%, and 0.021%, Ipratropium Bromide & Albuterol Sulfate (Generic DuoNeb®), Ipratropium Bromide 0.02%, and Sodium Chloride USP, 0.9%. Nephron was the first company to individually wrap and bar-code unit dose medications for patient safety. Nephron proudly manufactures all of our products in the USA.
Location: United States, South Carolina, West Columbia
Employees: 501-1000
Phone: +1 800-443-4313
Total raised: $425M
Founded date: 1997
Investors 1
| Date | Name | Website |
| - | Backcast P... | backcastpa... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 18.09.2023 | - | $350M | - |
| 22.08.2014 | - | $75M | - |
Mentions in press and media 7
| Date | Title | Description |
| 14.05.2024 | NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business Update | 2024 Catalysts: Positive Clinical Data, Two Planned NDAs, Company Launch of Hope Therapeutics; FDA QIDP award in cUTI and New Schizophrenia Opportunity Executed Term Sheet from an institutional investor for an initial $7.5 million note, sub... |
| 01.04.2024 | NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update | Four potential near-term milestones, including data from two clinical trials, an NDA filing and an upcoming share dividend -- 50% reduction in corporate overhead and 25% reduction in overall net loss in 2023, compared to 2024 with $0.20 per... |
| 18.09.2023 | Nephron Pharmaceuticals Raises $350M | Nephron Pharmaceuticals, a West Columbia, SC-based provider of inhalation solutions and suspension products, raised $350M in funding. The round was led by BlackRock Capital Investment Advisors, PNC Bank, and National Association. The compan... |
| 25.10.2022 | Nephron SC Inc. - 634647 - 10/11/2022 | Delivery Method: VIA Electronic Mail Product: Drugs Recipient: Recipient Name Ms. Lou W. Kennedy Recipient Title Chief Executive Officer and Owner Nephron SC Inc. 4500 12th Street Ext. West Columbia, SC 29172 United States lkennedy@nephronp... |
| 31.03.2021 | ISPE Foundation Partners with Nephron Pharmaceuticals Corporation on Diversity Internship Program | Over the coming years, a diverse pool of very talented students will be engaged in a variety of technologically stimulating projects under the guidance and mentorship of Nephron Pharmaceuticals scientists and engineers. NORTH BETHESDA, Md. ... |
| 22.08.2014 | Generic drugmaker Nephron Pharmaceuticals raises $75 million in debt financing | Promoted Clinical Care Capacity Planning Learn how to manage clinical care capacity more efficiently during uncertain times. SAP Promoted This Patient Experience Checklist Is Your Key To Success in 2021 As healthcare systems strive to recov... |
| - | Generic drugmaker Nephron Pharmaceuticals raises $75 million in debt financing | Nephron Pharmaceuticals, a maker of generic respiratory meds, has raised $75 million in debt financing, according to a regulatory filing. The company is based in Orlando, Florida and employs about 500. It announced two years ago that it wou... |